Document is current
Any future updates will be listed below
-
Authors
Wang, Xu-Wen https://orcid.org/0000-0001-7670-3544
Madeddu, Lorenzo
Spirohn, Kerstin https://orcid.org/0000-0002-2071-1606
Martini, Leonardo
Fazzone, Adriano https://orcid.org/0000-0002-3062-4485
Becchetti, Luca
Wytock, Thomas P. https://orcid.org/0000-0001-5204-1064
Kovács, István A.
Balogh, Olivér M. https://orcid.org/0000-0002-6296-6383
Benczik, Bettina
Pétervári, Mátyás
Ágg, Bence https://orcid.org/0000-0002-6492-0426
Ferdinandy, Péter
Vulliard, Loan https://orcid.org/0000-0002-2260-4935
Menche, Jörg https://orcid.org/0000-0002-1583-6404
Colonnese, Stefania
Petti, Manuela https://orcid.org/0000-0002-0149-161X
Scarano, Gaetano https://orcid.org/0000-0002-1120-707X
Cuomo, Francesca
Hao, Tong https://orcid.org/0000-0001-7908-3256
Laval, Florent https://orcid.org/0000-0001-7744-6199
Willems, Luc
Twizere, Jean-Claude https://orcid.org/0000-0002-8683-705X
Vidal, Marc
Calderwood, Michael A. https://orcid.org/0000-0001-6475-1418
Petrillo, Enrico https://orcid.org/0000-0002-9119-5434
Barabási, Albert-László
Silverman, Edwin K.
Loscalzo, Joseph https://orcid.org/0000-0002-1153-8047
Velardi, Paola
Liu, Yang-Yu https://orcid.org/0000-0003-2728-4907
- License Information
-
More Information
Article History
Received: 24 February 2022
Accepted: 2 March 2023
First Online: 22 March 2023
Competing interests
: PF is the founder and CEO of Pharmahungary Group, a group of R&D companies. EKS has received institutional grant support from Bayer and GlaxoSimthKline. A-LB is co-scientific founder of and is supported by Scipher Medicine, Inc., which applies network medicine strategies to biomarker development and personalized drug selection, and is the founder of Naring Inc., which applies data science to health and nutrition. The remaining authors declare no competing interests.
